Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Editas Medicine
300 Third St.
Cambridge, MA 02142
Phone: 617-401-9000
http://editasmedicine.com/

Editas' mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. The company's five founders have published much of the foundational work that has elevated genome editing technology to a level where it can now be optimized and developed for therapeutic use. The company has generated substantial patent filings and has access to intellectual property covering foundational genome editing technologies, as well as essential advancements and enablements that will uniquely allow the company to translate early findings into viable human therapeutic products.

Key Contact
Name
Katrine Bosley
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/26/13 $43,000,000 Series A Flagship Ventures
Partners Innovation Fund
Polaris Partners
Third Rock Ventures
undisclosed
08/10/15 $120,000,000 Series B bng0
Cowen Investments
Deerfield Management Company, L.P.
EcoR1 Capital
Fidelity Investments
Flagship Ventures
Khosla Ventures
Polaris Partners
T. Rowe Price Associates
Third Rock Ventures
Viking Global Investors
undisclosed